Source - RNS
RNS Number : 1966H
Quantum Pharma PLC
06 June 2017
 

For immediate release

6 June 2017

 

Quantum Pharma Plc

('Quantum' or the 'Company')

 

Annual Report and Accounts

Notice of Annual General Meeting

 

Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier, announces that in accordance with AIM Rule 20, electronic copies of its Annual Report and Accounts for the year ended 31 January 2017 together with the Notice of Annual General Meeting and Form of Proxy are available from the Company's investor relations website at http://ir.quantumpharmagroup.com/ .  Hard copies of the 2017 Annual Report and Accounts, Notice of Annual General Meeting and Form of Proxy were posted to shareholders yesterday.

 

The Company's Annual General Meeting will be held at 1:00 p.m. on Thursday, 6 July 2017 at the offices of Muckle LLP, Time Central, 32 Gallowgate, Newcastle upon Tyne, NE1 4BF.

 

- Ends -

 

For further information:

Quantum Pharma Plc

 

Chris Rigg, Chief Executive Officer

Tel: +44 (0) 1207 279 404

Gerard Murray, Chief Financial Officer

www.quantumpharmaplc.com

[email protected]

 

 

N+1 Singer

 

(Nominated Advisor & Broker)

 

Sandy Fraser / Nick Owen / James White

Tel: +44 (0) 20 7496 3000

 

Media enquiries:

Buchanan

 

Henry Harrison-Topham / Sophie Cowles

Tel: +44 (0) 20 7466 5000

[email protected]

www.buchanan.uk.com

 

Notes to Editors

Quantum Pharma Plc is a service-led, niche pharmaceutical developer, manufacturer and supplier to the retail pharmacy, pharmaceutical wholesale, hospital and homecare markets. Quantum Pharma Plc operates through three divisions - Specials, Niche Pharmaceuticals and Medication Adherence - offering a portfolio of innovative and complementary products and services.

 

For further information, please visit www.quantumpharmaplc.com.  


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUVONRBVANRAR